Every man desires to have a perfectly sculpted figure. When men see their six-pack abs, bulging biceps, and perfectly formed calves reflected in the mirror, they cannot help but feel better about ...

The European Medicines Agency (EMA) has recommended approval of Somatropin Biopartners (BioPartners), a new recombinant human growth hormone (rhGH) for long-term treatment of growth failure in ...

The HGH-X2 formula is designed to aid in the “release” of human growth hormone, which is generated by the pituitary gland. It’s important to note that this supplement does not include any HGH, which ...

Somatropin, also known as human growth hormone (HGH), is a synthetic version of the naturally occurring hormone produced by the pituitary gland. It plays a crucial role in various physiological ...

COPENHAGEN, Denmark, July 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has approved SKYTROFA ® (lonapegsomatropin-tcgd ...

This pivotal phase 3 trial led to the recent approval of lonapegsomatropin for growth hormone deficiency. A recent study detailed the findings of a pivotal phase 3 trial that evaluated the efficacy, ...

The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections. The FDA recently approved the first once-weekly somatropin injection for pediatric patients 1 ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global somatropin market is estimated to be valued at US$ 5.02 billion in 2020 and is expected to exhibit a CAGR of 7.9% during the ...

First of many planned label expansions supporting Vision 2030 goal to become the leading endocrinology rare disease company On track to initiate basket trial for ISS, SHOX deficiency, Turner syndrome, ...